BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Pharmacogenetics
,
Clofibrate
,
rs7903146
,
VEGFA
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
canertinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
WIF1
GPX3
HBB
COL11A1
RBP4
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
regulation of nitrogen compound metabolic process
organic cyclic compound binding
heterocyclic compound binding
vesicle
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Retinal and Conjunctival Vessels in the Diagnosis and Assessment of Behcet's Disease: A New Approach…
Canertinib induces ototoxicity in three preclinical models.
Role of empirical isolation of the superior vena cava in patients with recurrence of atrial fibrilla…
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Geographic Variation and Environmental Predictors of Nontuberculous Mycobacteria in Laboratory Surve…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subpr…
A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small …
A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ